Hepatic 3D spheroid models for the detection and study of compounds with cholestatic liability
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Drug-induced cholestasis (DIC) is poorly understood and its preclinical prediction is mainly limited to assessing the compound’s potential to inhibit the bile salt export pump (BSEP). Here, we evaluated two 3D spheroid models, one from primary human hepatocytes (PHH) and one from HepaRG cells, for the detection of compounds with cholestatic liability. By repeatedly co-exposing both models to a set of compounds with different mechanisms of hepatotoxicity and a non-toxic concentrated bile acid (BA) mixture for 8 days we observed a selective synergistic toxicity of compounds known to cause cholestatic or mixed cholestatic/hepatocellular toxicity and the BA mixture compared to exposure to the compounds alone, a phenomenon that was more pronounced after extending the exposure time to 14 days. In contrast, no such synergism was observed after both 8 and 14 days of exposure to the BA mixture for compounds that cause non-cholestatic hepatotoxicity. Mechanisms behind the toxicity of the cholestatic compound chlorpromazine were accurately detected in both spheroid models, including intracellular BA accumulation, inhibition of ABCB11 expression and disruption of the F-actin cytoskeleton. Furthermore, the observed synergistic toxicity of chlorpromazine and BA was associated with increased oxidative stress and modulation of death receptor signalling. Combined, our results demonstrate that the hepatic spheroid models presented here can be used to detect and study compounds with cholestatic liability.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“3D spheroid models are reported to produce more accurate assessment of acute and possibly also chronic drug-induced hepatotoxicity than traditional 2D culture models (Messner et al. 2013) and to be capable of detecting compounds with cholestatic liability (Hendriks et al. 2016).”
From Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury (2017) · cites this paper as Hendriks et al. 2016
The cited source says what the claim attributes to it.
In the citing paper
“However, a recent report suggested that bile-acid transport inhibition might be involved in part in bosentan-induced cytotoxicity in this model.”
From Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury (2017) · cites this paper as Hendriks et al. 2016
The cited source says what the claim attributes to it.
In the citing paper
“Addition of extracellular bile acids in the cell-culture media caused increased cytotoxicity of liver spheroid cultures relative to normal media treated spheroid cultures treated with bosentan over 14 day (Hendriks et al. 2016).”
From Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury (2017) · cites this paper as Hendriks et al. 2016
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bile salt transporters: molecular characterization, function, and regulation
Trauner, M., & Boyer, J. L. (2003) · Physiological Reviews · doi:10.1152/physrev.00027.2002 · Cited by 999
Bell, C. C., Hendriks, D. F. G., Moro, S. M. L., Ellis, E., Walsh, J., Renblom, A., Fredriksson Puigvert, L., Dankers, A. C. A., Jacobs, F., Snoeys, J., et al. (2016) · Scientific Reports · doi:10.1038/srep25187 · Cited by 739
Self-citationOutcome and prognostic markers in severe drug‐induced liver disease†
Björnsson, E., & Olsson, R. (2005) · Hepatology · doi:10.1002/hep.20800 · Cited by 524
Landry, J., Bernier, D., Ouellet, C., Goyette, R., & Marceau, N. (1985) · The Journal of cell biology · doi:10.1083/jcb.101.3.914 · Cited by 520
Bile Acid Sulfation: A Pathway of Bile Acid Elimination and Detoxification
Alnouti, Y. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfn268 · Cited by 390
Padda, M. S., Sanchez, M., Akhtar, A. J., & Boyer, J. L. (2011) · Hepatology · doi:10.1002/hep.24229 · Cited by 387
Swift*, B., Pfeifer*, N. D., & Brouwer, K. L. R. (2010) · Drug Metabolism Reviews · doi:10.3109/03602530903491881 · Cited by 365
Dawson, S., Stahl, S., Paul, N., Barber, J., & Kenna, J. G. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.040758 · Cited by 343
Morgan, R. E., Trauner, M., van Staden, C. J., Lee, P. H., Ramachandran, B., Eschenberg, M., Afshari, C. A., Qualls, C. W., Lightfoot-Dunn, R., & Hamadeh, H. K. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq269 · Cited by 325
Multi-cell type human liver microtissues for hepatotoxicity testing
Messner, S., Agarkova, I., Moritz, W., & Kelm, J. M. (2013) · Archives of Toxicology · doi:10.1007/s00204-012-0968-2 · Cited by 319
Self-citationMaher, J. M., Dieter, M. Z., Aleksunes, L. M., Slitt, A. L., Guo, G., Tanaka, Y., Scheffer, G. L., Chan, J. Y., Manautou, J. E., Chen, Y., et al. (2007) · Hepatology · doi:10.1002/hep.21831 · Cited by 315
Funk, C., Ponelle, C., Scheuermann, G., & Pantze, M. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12255-9 · Cited by 296
The future of drug safety testing: expanding the view and narrowing the focus
Stevens, J. L., & Baker, T. K. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2008.11.009 · Cited by 286
Hepatobiliary transporters and drug‐induced cholestasis†
Pauli‐Magnus, C., & Meier, P. J. (2006) · Hepatology · doi:10.1002/hep.21359 · Cited by 285
Sokol, R. J., Winklhofer-Roob, B. M., Devereaux, M. W., & McKim, J. M. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90585-5 · Cited by 275
Stieger, B. (2011) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-14541-4_5 · Cited by 269
Human liver cell spheroids in extended perfusion bioreactor culture for repeated-dose drug testing
Tostões, R. M., Leite, S. B., Serra, M., Jensen, J., Björquist, P., Carrondo, M. J. T., Brito, C., & Alves, P. M. (2012) · Hepatology · doi:10.1002/hep.24760 · Cited by 246
Morgan, R. E., van Staden, C. J., Chen, Y., Kalyanaraman, N., Kalanzi, J., Dunn, R. T., Afshari, C. A., & Hamadeh, H. K. (2013) · Toxicological Sciences · doi:10.1093/toxsci/kft176 · Cited by 243
3D Organotypic Cultures of Human HepaRG Cells: A Tool for In Vitro Toxicity Studies
Gunness, P., Mueller, D., Shevchenko, V., Heinzle, E., Ingelman-Sundberg, M., & Noor, F. (2013) · Toxicological Sciences · doi:10.1093/toxsci/kft021 · Cited by 236
Self-citationLübberstedt, M., Müller-Vieira, U., Mayer, M., Biemel, K. M., Knöspel, F., Knobeloch, D., Nüssler, A. K., Gerlach, J. C., & Zeilinger, K. (2011) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2010.04.013 · Cited by 227
Bile salts mediate hepatocyte apoptosis by increasing cell surface trafficking of Fas
Sodeman, T., Bronk, S. F., Roberts, P. J., Miyoshi, H., & Gores, G. J. (2000) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2000.278.6.g992 · Cited by 216
The Bile Acid Glycochenodeoxycholate Induces TRAIL-Receptor 2/DR5 Expression and Apoptosis
Higuchi, H., Bronk, S. F., Takikawa, Y., Werneburg, N., Takimoto, R., El-Deiry, W., & Gores, G. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105300200 · Cited by 186
Hirata, K., Takagi, H., Yamamoto, M., Matsumoto, T., Nishiya, T., Mori, K., Shimizu, S., Masumoto, H., & Okutani, Y. (2008) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500442 · Cited by 185
Funk, C. (2001) · Toxicology · doi:10.1016/s0300-483x(01)00460-7 · Cited by 177
Oxidative stress plays a major role in chlorpromazine-induced cholestasis in human HepaRG cells
Anthérieu, S., Azzi, P. B.-E., Dumont, J., Abdel-Razzak, Z., Guguen-Guillouzo, C., Fromenty, B., Robin, M.-A., & Guillouzo, A. (2013) · Hepatology · doi:10.1002/hep.26160 · Cited by 145
Fréneaux, E., Labbe, G., Letteron, P., Dinh, T. L., Degott, C., Genève, J., Larrey, D., & Pessayre, D. (1988) · Hepatology · doi:10.1002/hep.1840080513 · Cited by 144
Higuchi, H., Grambihler, A., Canbay, A., Bronk, S. F., & Gores, G. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309476200 · Cited by 143
Transcriptional Regulation of the AP-1 and Nrf2 Target Gene Sulfiredoxin
Soriano, F. X., Baxter, P., Murray, L. M., Sporn, M. B., Gillingwater, T. H., & Hardingham, G. E. (2009) · Molecules and Cells · doi:10.1007/s10059-009-0050-y · Cited by 142
Heslop, J. A., Rowe, C., Walsh, J., Sison-Young, R., Jenkins, R., Kamalian, L., Kia, R., Hay, D., Jones, R. P., Malik, H. Z., et al. (2017) · Archives of Toxicology · doi:10.1007/s00204-016-1694-y · Cited by 141
Proteome-Wide Analyses of Human Hepatocytes During Differentiation and Dedifferentiation
Rowe, C., Gerrard, D. T., Jenkins, R., Berry, A., Durkin, K., Sundstrom, L., Goldring, C. E., Park, K. B., Kitteringham, N. R., Hanley, K. P., et al. (2013) · Hepatology · doi:10.1002/hep.26414 · Cited by 133
Yang, K., Köck, K., Sedykh, A., Tropsha, A., & Brouwer, K. L. R. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23584 · Cited by 114
Rodrigues, A. D., Lai, Y., Cvijic, M. E., Elkin, L. L., Zvyaga, T. A., & Soars, M. G. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.054205 · Cited by 113
Xiang, X., Han, Y., Neuvonen, M., Laitila, J., Neuvonen, P. J., & Niemi, M. (2009) · Journal of Chromatography B · doi:10.1016/j.jchromb.2009.11.019 · Cited by 112
IV. Bile acids and death receptors
Higuchi, H., & Gores, G. J. (2003) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00491.2002 · Cited by 112
Hepatocyte-based in vitro model for assessment of drug-induced cholestasis
Chatterjee, S., Richert, L., Augustijns, P., & Annaert, P. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.10.032 · Cited by 99
Tan, K. P., Yang, M., & Ito, S. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.039370 · Cited by 99
Nuclear receptors as drug targets in cholestasis and drug-induced hepatotoxicity
Zollner, G., Wagner, M., & Trauner, M. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.03.005 · Cited by 96
Azzi, P. B.-E., Sharanek, A., Burban, A., Li, R., Guével, R. L., Abdel‐Razzak, Z., Stieger, B., Guguen‐Guillouzo, C., & Guillouzo, A. (2015) · Toxicological Sciences · doi:10.1093/toxsci/kfv041 · Cited by 88
The Role of Bile Salt Export Pump Gene Repression in Drug-Induced Cholestatic Liver Toxicity
Garzel, B., Yang, H., Zhang, L., Huang, S. M., Polli, J. E., & Wang, H. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.054189 · Cited by 83
Role of Bile Acids in Liver Injury and Regeneration following Acetaminophen Overdose
Bhushan, B., Borude, P., Edwards, G., Walesky, C., Cleveland, J., Li, F., Ma, X., & Apte, U. (2013) · The American Journal of Pathology · doi:10.1016/j.ajpath.2013.07.012 · Cited by 79
Sharanek, A., Azzi, P. B.-E., Al‐Attrache, H., Savary, C. C., Humbert, L., Rainteau, D. P., Guguen‐Guillouzo, C., & Guillouzo, A. (2014) · Toxicological Sciences · doi:10.1093/toxsci/kfu122 · Cited by 78
Gustafsson, F., Foster, A. J., Sarda, S., Bridgland-Taylor, M. H., & Kenna, J. G. (2014) · Toxicological Sciences · doi:10.1093/toxsci/kft223 · Cited by 77
Ansede, J. H., Smith, W. R., Perry, C. H., Claire, R. L. S., & Brouwer, K. R. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.028407 · Cited by 77
Chen, P., Zeng, H., Wang, Y., Fan, X., Xu, C., Deng, R., Zhou, X., Bi, H., & Huang, M. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.056549 · Cited by 76
Drug-induced cholestasis risk assessment in sandwich-cultured human hepatocytes
Oorts, M., Baze, A., Bachellier, P., Heyd, B., Zacharias, T., Annaert, P., & Richert, L. (2016) · Toxicology in Vitro · doi:10.1016/j.tiv.2016.03.008 · Cited by 66
Case series of liver failure associated with rosiglitazone and pioglitazone
Floyd, J. S., Barbehenn, E., Lurie, P., & Wolfe, S. M. (2009) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1804 · Cited by 64
Roma, M. G., Milkiewicz, P., Elias, E., & Coleman, R. (2000) · Hepatology · doi:10.1053/jhep.2000.20519 · Cited by 61
Ticlopidine-Induced Cholestatic Hepatitis
Skurnik, Y. D., Tcherniak, A., Edlan, K., & Sthoeger, Z. (2003) · Annals of Pharmacotherapy · doi:10.1345/aph.1a406 · Cited by 50
Roman, I. D. (2003) · Toxicological Sciences · doi:10.1093/toxsci/71.2.276 · Cited by 49
Azzi, P. B.-E., Sharanek, A., Abdel‐Razzak, Z., Anthérieu, S., Al‐Attrache, H., Savary, C. C., Lepage, S., Morel, I., Labbe, G., Guguen‐Guillouzo, C., et al. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.058123 · Cited by 40
Yoshikado, T., Takada, T., Yamamoto, H., Tan, J. K., Ito, K., Santa, T., & Suzuki, H. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.081752 · Cited by 21
Cited by
Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury
Proctor, W. R., Foster, A. J., Vogt, J., Summers, C., Middleton, B., Pilling, M. A., Shienson, D., Kijanska, M., Ströbel, S., Kelm, J. M., et al. (2017) · Archives of Toxicology · doi:10.1007/s00204-017-2002-1 · Cited by 328
“Taken together, the findings in this report in addition to the recent published report by Hendriks et al. (2016) support that hLiMT may be a valuable in vitro tool to evaluate the functional and phenotypic (e.g., cytotoxicity) effects of bile-acid transport inhibition in an intact hepatocellular…”
BackgroundResultInfluentialSelf-citationHuman Pluripotent Stem Cell-Derived Organoids as Models of Liver Disease
Ramli, M. N. B., Lim, Y. S., Koe, C. T., Demircioglu, D., Tng, W., Gonzales, K. A. U., Tan, C. P., Szczerbinska, I., Liang, H., Soe, E. L., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.06.010 · Cited by 278
The evolving role of investigative toxicology in the pharmaceutical industry
Pognan, F., Beilmann, M., Boonen, H. C. M., Czich, A., Dear, G., Hewitt, P., Mow, T., Oinonen, T., Roth, A., Steger-Hartmann, T., et al. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00633-x · Cited by 255
Weaver, R. J., Blomme, E. A., Chadwick, A. E., Copple, I. M., Gerets, H. H. J., Goldring, C. E., Guillouzo, A., Hewitt, P. G., Ingelman-Sundberg, M., Jensen, K. G., et al. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0048-x · Cited by 249
Self-citationHuman hepatic 3D spheroids as a model for steatosis and insulin resistance
Kozyra, M., Johansson, I., Nordling, Å., Ullah, S., Lauschke, V. M., & Ingelman-Sundberg, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-32722-6 · Cited by 173
Self-citation
Metadata
- Authors
- Hendriks, D. F. G., Fredriksson Puigvert, L., Messner, S., Mortiz, W., & Ingelman-Sundberg, M.
- Affiliations
- Karolinska Institutet (SE)
- Venue
- Scientific Reports
- Published
- 2016-10-19
- Volume
- 6
- Issue
- 1
- Pages
- 35434-35434
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC5069690
- OpenAlex
- W2539243243
- Cited by
- 156
- References
- 51
- Citations by year
- 2026: 8 · 2025: 14 · 2024: 12 · 2023: 10 · 2022: 17 · 2021: 18 · 2020: 26 · 2019: 23 · 2018: 18 · 2017: 10
- FWCI
- 21.37
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- European Commission (115336, 267038)
- Vetenskapsrådet (FP7/2007-2013)
- Staatssekretariat für Bildung, Forschung und Innovation
- Eurostars
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Keywords
- drug-induced cholestasis, primary human hepatocytes, HepaRG cells, bile salt export pump, bile acids, synergistic toxicity, chlorpromazine, hepatotoxicity, ABCB11, F-actin cytoskeleton, oxidative stress, death receptor signaling
- MeSH terms
- Bile Acids and Salts, Biological Transport, Cell Line, Chlorpromazine, Cholestasis, Humans, Signal Transduction, Oxidative Stress, Spheroids, Cellular, Cell Culture Techniques, Hepatocytes, Receptors, TNF-Related Apoptosis-Inducing Ligand, Chemical and Drug Induced Liver Injury
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.